Cytarabine | C9H13N3O5 - PubChem
Genetic factors influencing cytarabine therapy | Pharmacogenomics
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
Melphalan and Cytarabine as a Salvage Therapy in Children with Relapsed or Refractory Acute Leukemia
AML Refractory to 1 Cycle of High-Dose Cytarabine-Based Induction Chemotherapy
OUTCOME OF STANDARD INDUCTION THERAPY WITH DAUNORUBICIN AND ARA-C (3+7) IN ACUTE MYELOID LEUKEMIA
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial - The
Adult myeloid leukaemias: current and future treatments - The Pharmaceutical Journal
Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study | Leukemia
352-Consolidation HiDAC (cytarabine) 1,3,5 | eviQ
Cytarabine (Cytarabine): Uses, Dosage, Side Effects, Interactions, Warning
Chemotherapy dosing schedule. The schedule for ARA-C (200 mg/m 2 /d),... | Download Scientific Diagram
A Comparative Study of Two Different Doses of Cytarabine for Acute Myeloid Leukemia: A Phase III Trial of Cancer and Leukemia Group B - ScienceDirect
Cytarabine - Wikipedia
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers
Chemotherapy regimen. | Download Table
Flowchart of regimen consisting of cladribine, cytarabine and etoposide... | Download Scientific Diagram
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia | Future Oncology
Improved chemotherapy modeling with RAG-based immune deficient mice | PLOS ONE
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
7+3 (daunorubicin) for AML | ChemoExperts
